[1]付平.提升中国慢性肾脏病患者自我管理的综合策略[J].肾脏病与透析肾移植杂志, 2023, 32(06):551-553
[2]KRüGER-GENGE A, BLOCKI A, FRANKE R P, et at.Vascular Endothelial Cell Biology: An Update[JOL][J].International Journal of Molecular Sciences, 2019, 20(18):4411--
[3] JAIN N, CORKEN A, KUMAR A, et at.Role of Platelets in Chronic Kidney Disease[J/OL]. [J].Journal of the American Society of Nephrology, 2021, 32(7):1551-1558
[4] SHINKAWA K, YOSHIDA S, SEKI T, et at.Risk factors of venous thromboembolism in patients with nephrotic syndrome: a retrospective cohort study[J/OL]. [J].Nephrology, dialysis, transplantation, 2020, gfaa(134):1-8
[5]VESTERGAARD S V, BIRN H, DARVALICS B, et at.Risk of Arterial Thromboembolism,Venous Thromboembolism,and Bleeding in Patients with Nephrotic Syndrome: A Population-Based Cohort Study[JOL][J].The American Journal of Medicine, 2022, 135(5):615-625
[6]WELANDER F, HOLMBERG H, DIMéNY E, et at.Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome-A retrospective observational study[JOL][J].PloS One, 2021, 16(7):e0255009--
[7]HAN X, ZHAO P, WANG Z, et at.Acute lower extremity arterial thrombosis associated with nephrotic syndrome in adults: case series and literature review[JOL][J].BMC nephrology, 2023, 24(1):318-318
[8] SHATTIL S J, COOPER R A, 1978.Role of membrane lipid composition, organization, and fluidity in human platelet function[J].[J].Progress in Hemostasis and Thrombosis,, 1978, 4(-):59-86
[9] MAHMOODI BK, GANSEVOORT, NAESS, et al.Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts[J].Circulation, 2012, 126(16):1964-1971
[10]OCAK G, LIJFERING W M, VERDUIJN M, et al.Risk of venous thrombosis in patients with chronic kidney disease: identification of high-risk groups[JOL][J].Journal of thrombosis and haemostasis: JTH, 2013, 11(4):627-633
[11] RATTAZZI M, VILLALTA S, DE LUCCHI L, et al.Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence[J/OL].[J]. Thrombosis Research, 2017, 160(-):32-37
[12]YUAN S, BRUZELIUS M, LARSSON SC.. Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization investigation [J].Journal of thrombosis and thrombolysis, 2022, 53(1):43-50
[13]YU G, JIANG Y, XU Z, et al.Plasma D-dimer as a potential predictor of progression in IgA nephropathy: a cohort study[JOL][J].Renal Failure, 2023, 45(2):2251587--
[14]HUANG M J, WEI R B, WANG Y, et al.Blood coagulation system in patients with chronic kidney disease: a prospective observational study[JOL][J].BMJ open, 2017, 7(5):e014294--
[15]YU G, JIANG Y, XU Z, et al.Plasma D-dimer as a potential predictor of progression in IgA nephropathy: a cohort study[JOL][J].Renal Failure, 2023, 45(2):2251587--
[16] YEN C C, HSU P C, LIN C C, et al.Effect of far-infrared radiation therapy on von Willebrand factor in patients with chronic kidney disease[J/OL]. [J].Frontiers in Medicine, 2023, 10(-):1268212--
[17]SKYE S M, ZHU W, ROMANO K A, et al.Microbial Transplantation with Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential[JOL][J].Circulation research, 2018, 123(10):1164-1176
[18]ZHU W, WANG Z, TANG W H W, et al.Gut Microbe-Generated Trimethylamine N-Oxide From Dietary Choline Is Prothrombotic in Subjects[JOL][J].Circulation, 2017, 135(17):1671-1673
[19]ZHU W, GREGORY J C, ORG E, et al.Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk[JOL][J].Cell, 2016, 165(1):111-124
[20]SELDIN M M, MENG Y, QI H, et al.Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB[JOL][J].Journal of the American Heart Association, 2016, 5(2):e002767--
[21] Trimethylamine N-oxide promotes tissue factor expression and activity in vascular endothelial cells: A new link between trimethylamine N-oxide and atherosclerotic thrombosis - PubMed[EB/OL].[2024-01-24]. https://pubmed.ncbi.nlm.nih.gov/30875490/.[J].Thrombosis research, 2019, 177(-):110-117
[22]NEMET I, SAHA P P, GUPTA N, et at.A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors[J].Cell, 2020, 180(5):862-877
[23]WU I W, HSU K H, HSU H J, et at.Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study[JOL][J].Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association, 2012, 27(3):1169-1175
[24] BHARTI N, RAI M K, SINGH S, et at.Prognostic significance of circulating microparticles in IgA nephropathy[J/OL]. [J].International Urology and Nephrology, 2023, -(-):---
[25]TSAI L T, WENG T I, CHANG T Y, et at.Inhibition of Indoxyl Sulfate-Induced Reactive Oxygen Species-Related Ferroptosis Alleviates Renal Cell Injury In Vitro and Chronic Kidney Disease Progression In Vivo[JOL][J].Antioxidants (Basel, Switzerland), 2023, 12(11):1931--
[26]YANG K, DU C, WANG X, et at.Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease-associated thrombosis in mice[JOL][J].Blood, 2017, 129(19):2667-2679
[27]GONDOUIN B, CERINI C, DOU L, et at.Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway[JOL][J].Kidney International, 2013, 84(4):733-744
[28]WANG I K, SHEN T C, MUO C H, et at.Risk of pulmonary embolism in patients with end-stage renal disease receiving long-term dialysis[JOL][J].Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association, 2017, 32(8):1386-1393
[29] K?NIGSBRüGGE O, LORENZ M, AUINGER M, et at.Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI)[J/OL]. [J].Thrombosis Research, 2017, 158(-):59-64
[30] BRASH J L, HORBETT T A, LATOUR R A, et at.The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity[J/OL]. [J].Acta Biomaterialia, 2019, 94(-):11-24
[31]FRAN?OIS K, ORLANDO C, JOCHMANS K, et at.Hemodialysis Does Not Induce Detectable Activation of the Contact System of Coagulation[JOL][J].Kidney International Reports, 2020, 5(6):831-838
[32] KOURTZELIS I, MARKIEWSKI M M, DOUMAS M, et at.Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis[J/OL]. [J].Blood, 2010, 116(4):631-639
[33]HAMAD O A, MITROULIS I, FROMELL K, et at.Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11bCD18[JOL][J].Thrombosis and Haemostasis, 2015, 114(6):1207-1217
[34]EKDAHL K N, FROMELL K, MANNES M, et at.Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop[JOL][J].Immunological Reviews, 2023, 313(1):91-103
[35]BOWRY S K, KIRCELLI F, HIMMELE R, et at.Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation[JOL][J].Clinical Kidney Journal, 2021, 14(Suppl 4):i59-i71
[36]CHEN Z, MONDAL N K, ZHENG S, et at.High shear induces platelet dysfunction leading to enhanced thrombotic propensity and diminished hemostatic capacity[JOL][J].Platelets, 2019, 30(1):112-119
[37] JI H, LI Y, SU B, ZHAO W, KIZHAKKEDATHU, ZHAO C..Advances in Enhancing Hemocompatibility of Hemodialysis Hollow-Fiber Membranes - PubMed[EB/OL][J]. Advanced fiber materials, 2023, 3(-):1-43
